Literature DB >> 31025383

Induction of CD137 expression by viral genes reduces T cell costimulation.

Meihui Wu1,2, Hiu Yi Wong1,2, Jia Le Lin1,2, Annalena Moliner2, Herbert Schwarz1,2.   

Abstract

Intracellular pathogens are subject to elimination by a cellular immune response, and were therefore under evolutionary pressure to develop mechanisms that allow them to inhibit especially this arm of immunity. CD137, a T cell costimulatory molecule, and its ligand, CD137 ligand (CD137L), which is expressed on antigen presenting cells (APC), are potent drivers of cellular cytotoxic immune responses. Here, we report that different viruses usurp a negative feedback mechanism for the CD137-CD137L system that weakens cellular immune responses. Latent membrane protein (LMP)-1 and Tax, oncogenes of Epstein-Barr virus (EBV), and human T-cell lymphotropic virus (HTLV)-1, respectively, induce the expression of CD137. CD137 is transferred by trogocytosis to CD137L-expressing APC, and the CD137-CD137L complex is internalized and degraded, resulting in a reduced CD137-mediated T cell costimulation and a weakened cellular immune response which may facilitate the escape of the virus from immune surveillance. These data identify the usurpation of a CD137-based negative feedback mechanism by intracellular pathogens that enables them to reduce T cell costimulation.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  CD137; EBV; HTLV-1; LMP-1; Tax; immune evasion

Mesh:

Substances:

Year:  2019        PMID: 31025383     DOI: 10.1002/jcp.28710

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  8 in total

1.  Epstein-Barr virus-induced ectopic CD137 expression helps nasopharyngeal carcinoma to escape immune surveillance and enables targeting by chimeric antigen receptors.

Authors:  Mukul Prasad; Sashigala Ponnalagu; Qun Zeng; Khang Luu; Si Min Lang; Hiu Yi Wong; Man Si Cheng; Meihui Wu; Karthik Mallilankaraman; Radoslaw Mikolaj Sobota; Yan Ting Lim; Loo Chien Wang; Chuan Keng Goh; Kai Xun Joshua Tay; Kwok Seng Loh; Cheng-I Wang; Wen-Hsien Lee; Boon Cher Goh; Chwee Ming Lim; Herbert Schwarz
Journal:  Cancer Immunol Immunother       Date:  2022-03-17       Impact factor: 6.630

2.  Development of a Bispecific Antibody Targeting CD30 and CD137 on Hodgkin and Reed-Sternberg Cells.

Authors:  Sakthi Rajendran; Yating Li; Evelyn Ngoh; Hiu Yi Wong; Man Si Cheng; Cheng-I Wang; Herbert Schwarz
Journal:  Front Oncol       Date:  2019-09-24       Impact factor: 6.244

Review 3.  CD137L-DCs, Potent Immune-Stimulators-History, Characteristics, and Perspectives.

Authors:  Qun Zeng; Yubin Zhou; Herbert Schwarz
Journal:  Front Immunol       Date:  2019-10-02       Impact factor: 7.561

4.  Destroy, what destroys you.

Authors:  Khang Luu; Emily Nickles; Herbert Schwarz
Journal:  Oncoimmunology       Date:  2019-11-03       Impact factor: 8.110

5.  Ectopic CD137 expression by rhabdomyosarcoma provides selection advantages but allows immunotherapeutic targeting.

Authors:  Kang Yi Lee; Hiu Yi Wong; Qun Zeng; Jia Le Lin; Man Si Cheng; Chik Hong Kuick; Kenneth Tou En Chang; Amos Hong Pheng Loh; Herbert Schwarz
Journal:  Oncoimmunology       Date:  2021-02-04       Impact factor: 8.110

Review 6.  Immunopathogenesis and Cellular Interactions in Human T-Cell Leukemia Virus Type 1 Associated Myelopathy/Tropical Spastic Paraparesis.

Authors:  Sepehr Aghajanian; Majid Teymoori-Rad; Ghazale Molaverdi; Sayed-Hamidreza Mozhgani
Journal:  Front Microbiol       Date:  2020-12-22       Impact factor: 5.640

Review 7.  Gnawing Between Cells and Cells in the Immune System: Friend or Foe? A Review of Trogocytosis.

Authors:  Siyu Zhao; Lichao Zhang; Suoyu Xiang; Yunyi Hu; Zhongdao Wu; Jia Shen
Journal:  Front Immunol       Date:  2022-02-03       Impact factor: 7.561

Review 8.  The role of trogocytosis in immune surveillance of Hodgkin lymphoma.

Authors:  Qun Zeng; Herbert Schwarz
Journal:  Oncoimmunology       Date:  2020-06-17       Impact factor: 8.110

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.